Hogan Lovells 2024 Election Impact and Congressional Outlook Report
With so many developments across the globe in the area of sustainability-related disclosures, we have looked back throughout May 2022 and summarised the key points coming out of the EU, UK and US.
In December 2021 (although published in May 2022), the ESAs submitted to the EU Commission (“EC”) further queries relating to the interpretation of the SFDR and the Taxonomy Regulation (“TR”). A summary of the key questions for FMPs, along with the EC’s responses (published by ESMA on 25 May 2022), is set out below.
ESAs Question |
EC Response |
Comments |
---|---|---|
Principal adverse impact disclosures: whether an FMP that opts out of PAI disclosure at the entity level can still indicate that they consider PAIs under article 7? |
The EC has confirmed that it is possible to consider PAIs at the product level, even if an FMP does not consider PAIs at the entity level. |
Many FMPs consider PAIs at the product level without complying with Article 4, and indeed Article 9 products (and Article 8 products with “sustainable investments”) need to consider the PAIs as part of the “do no significant harm” test in any case. As such, this response is helpfully in line with the approach that has been adopted by the market to date.
|
Pre-contractual risk and PAI disclosures for products no longer made available: do the sustainability risk and PAI product level disclosures apply only to new financial products or also to products that existed as of the SFDR’s application date on 10 March 2021? |
The EC has confirmed that for existing financial products that were no longer made available to end investors as of 10 March 2021, FMPs did not need to comply with the pre-contractual disclosures but they must comply with the:
|
This decision is consistent with the view adopted by the market; pre-contractual disclosure requirements do not apply to existing closed products but periodic reporting and website requirements do apply. This will only bite on Article 8 and 9 products given that Articles 10 and 11 do not extend to Article 6 products. However, this also means that the EC expects FMPs to have undertaken a categorisation exercise of all in-scope products, including those that were not made available to new investors as of 10 March 2021. New raisings for any funds that were in a closed period as of 10 March 2021 will require SFDR-compliant pre-contractual disclosures. Again, this is consistent with the view that has been adopted by the market.
|
Scope of Articles 5 and 6 TR disclosures: do Article 8 SFDR products that do not invest in any “sustainable investments” need to make disclosures under Article 6 TR?
Do Article 9 SFDR products with a social objective still need to disclose under Article 5 TR where it subsequently makes environmental sustainable investments? |
Article 8 SFDR / Article 6 TR products The EC has confirmed that FMPs must make disclosures under Article 6 of the TR for all Article 8 SFDR products that promote environmental characteristics, whether or not they invest in economic activities that contribute to an environmental objective (i.e. “sustainable investments” as defined in Article 2(17) SFDR). Article 9 SFDR / Article 5 TR products The EC has confirmed that FMPs must make disclosures under Article 5 TR where an Article 9 SFDR product that initially commits to a social objective in its pre-contractual disclosures subsequently invests in economic activities contributing to an environmental objective. Data As a reminder, FMPs are required to use reliable data to disclose how and to what extent the investments underlying the financial product are in economic activities that qualify as environmentally sustainable under Article 3 TR. The ECs have:
|
This is inconsistent with:
We will be monitoring to see how the market responds to these inconsistencies. |
The EC has issued two (2) letters to the ESAs requesting that they propose amendments to the:
We will continue to monitor for further developments in this ever-evolving area.
Authored by Rita Hunter, and Paida Manhambara.